Article
A hypoxia risk signature for the tumor immune microenvironment evaluation and prognosis prediction in acute myeloid leukemia.
Scientific reports - 19 Jul 2021
Jiang Feng, Mao Yan, Lu Binbin, Zhou Guoping, Wang Jimei
Abstract excerpt
Acute myeloid leukemia (AML) is the most prevalent form of acute leukemia. Patients with AML often have poor clinical prognoses. Hypoxia can activate a series of immunosuppressive processes in tumors, resulting in diseases and poor clinical prognoses. However, how to evaluate the severity of hypoxia in tumor immune microenvironment remains unknown. In this study, we downloaded the profiles of RNA sequence and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
